Epipregnanolone (3β-hydroxy-5β-pregnan-20-one, Epi) is an endogenous steroid with important physiological effects and high affinity for GABAA receptors. The effect of Epi on GABA-induced chloride current (IGABA) in native neurons has hardly been studied. In this work, we studied the influence of Epi on the IGABA in the Purkinje cells of rat cerebellum and pyramidal neurons of rat hippocampus with the patch clamp technique. We showed that Epi is a positive modulator of the IGABA with EC50 of 5.7 µM in Purkinje cells and 9.3 µM in hippocampal neurons. Epi-induced potentiation of the IGABA was more potent at low vs. high GABA concentrations. Isopregnanolone (3β-hydroxy-5α-pregnan-20-one, Iso) counteracted Epi, reducing its potentiating effect by 2-2.3 times. Flumazenil, a nonsteroidal GABAA receptor antagonist, does not affect the Epi-induced potentiation. Comparison of the potentiating effects of Epi and allopregnanolone (3α-hydroxy-5α-pregnan-20-one, ALLO) showed that ALLO is, at least, a four times more potent positive modulator than Epi. The combined application of ALLO and Epi showed that the effects of these two steroids are not additive. We conclude that Epi has a dual effect on the IGABA increasing the current in the control solution and decreasing the stimulatory effect of ALLO.

Functional Synaptology Laboratory Brain Research Department Research Center of Neurology Volokolamskoe Shosse 80 125367 Moscow Russia

Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences Flemingovo Namesti 2 160 00 Prague Czech Republic

Zobrazit více v PubMed

Sugasawa Y., Cheng W.W., Bracamontes J.R., Chen Z.-W., Wang L., Germann A.L., Pierce S.R., Senneff T.C., Krishnan K., Reichert D.E., et al. Site-specific effects of neurosteroids on GABAA receptor activation and desensitization. eLife. 2020;9:e55331. doi: 10.7554/eLife.55331. PubMed DOI PMC

Bukanova J.V., Solntseva E.I., Kolbaev S.N., Kudova E. Modulation of GABA and glycine receptors in rat pyramidal hippocampal neurones by 3α5β-pregnanolone derivatives. Neurochem. Int. 2018;118:145–151. doi: 10.1016/j.neuint.2018.06.002. PubMed DOI

Miller P.S., Scott S., Masiulis S., De Colibus L., Pardon E., Steyaert J., Aricescu A.R. Structural basis for GABAA receptor potentiation by neurosteroids. Nat. Struct. Mol. Biol. 2017;24:986–992. doi: 10.1038/nsmb.3484. PubMed DOI PMC

Wang M., He Y., Eisenman L.N., Fields C., Zeng C.-M., Mathews J., Benz A., Fu T., Zorumski E., Covey D.F., et al. 3β-Hydroxypregnane steroids are pregnenolone sulfate-like GABA(A) receptor antagonists. J. Neurosci. 2002;22:3366–3375. doi: 10.1523/JNEUROSCI.22-09-03366.2002. PubMed DOI PMC

Poisbeau P., Feltz P., Schlicht R. Modulation of GABAA receptor-mediated IPSCs by neuroactive steroids in a rat hypothalamo-hypophyseal coculture model. J. Physiol. 1997;500 Pt 2:475–485. doi: 10.1113/jphysiol.1997.sp022034. PubMed DOI PMC

Le Foll F., Louiset E., Castel H., Vaudry H., Cazin L. Electrophysiological effects of various neuroactive steroids on the GABA(A) receptor in pituitary melanotrope cells. Eur. J. Pharmacol. 1997;331:303–311. doi: 10.1016/S0014-2999(97)01042-X. PubMed DOI

Weir C.J., Ling A.T.Y., Belelli D., Wildsmith J.A.W., Peters J.A. The interaction of anaesthetic steroids with recombinant glycine and GABAA receptors. Br. J. Anaesth. 2004;92:704–711. doi: 10.1093/bja/aeh125. PubMed DOI

Kokate T.G., Svensson B.E., Rogawski M.A. Anticonvulsant activity of neurosteroids: Correlation with gamma-aminobutyric acid-evoked chloride current potentiation. J. Pharmacol. Exp. Ther. 1994;270:1223–1229. PubMed

Strömberg J., Haage D., Taube M., Bäckström T., Lundgren P. Neurosteroid modulation of allopregnanolone and GABA effect on the GABA-A receptor. Neuroscience. 2006;143:73–81. doi: 10.1016/j.neuroscience.2006.07.031. PubMed DOI

Ayoola C., Hwang S.M., Hong S.J., Rose K.E., Boyd C., Bozic N., Park J.-Y., Osuru H.P., DiGruccio M.R., Covey D.F., et al. Inhibition of CaV3.2 T-type calcium channels in peripheral sensory neurons contributes to analgesic properties of epipregnanolone. Psychopharmacology. 2014;231:3503–3515. doi: 10.1007/s00213-014-3588-0. PubMed DOI PMC

Paul S.M., Pinna G., Guidotti A. Allopregnanolone: From molecular pathophysiology to therapeutics. A historical perspective. Neurobiol. Stress. 2020;12:100215. doi: 10.1016/j.ynstr.2020.100215. PubMed DOI PMC

O’Dell L.E., Purdy R.H., Covey D.F., Richardson H.N., Roberto M., Koob G.F. Epipregnanolone and a novel synthetic neuroactive steroid reduce alcohol self-administration in rats. Pharmacol. Biochem. Behav. 2005;81:543–550. doi: 10.1016/j.pbb.2005.03.020. PubMed DOI

Joksimovic S.L., Donald R.R., Park J.-Y., Todorovic S.M. Inhibition of multiple voltage-gated calcium channels may contribute to spinally mediated analgesia by epipregnanolone in a rat model of surgical paw incision. Channels. 2019;13:48–61. doi: 10.1080/19336950.2018.1564420. PubMed DOI PMC

Vorobjev V.S. Vibrodissociation of sliced mammalian nervous tissue. J. Neurosci. Methods. 1991;8:145–150. doi: 10.1016/0165-0270(91)90164-U. PubMed DOI

Hood S.D., Norman A., Hince D.A., Melichar J.K., Hulse G.K. Benzodiazepine dependence and its treatment with low dose flumazenil. Br. J. Clin. Pharmacol. 2014;77:285–294. doi: 10.1111/bcp.12023. PubMed DOI PMC

Li P., Shu H.-J., Wang C., Mennerick S., Zorumski C.F., Covey D.F., Steinbach J.H., Akk G. Neurosteroid migration to intracellular compartments reduces steroid concentration in the membrane and diminishes GABA-A receptor potentiation. J. Physiol. 2007;584 Pt 3:789–800. doi: 10.1113/jphysiol.2007.142794. PubMed DOI PMC

Pignataro L., de Plazas S.F. Epipregnanolone acts as a partial agonist on a common neurosteroid modulatory site of the GABA(A) receptor complex in avian CNS. Neurochem. Res. 1997;22:221–225. doi: 10.1023/A:1027327910138. PubMed DOI

Prince R.J., Simmonds M.A. Differential antagonism by epipregnanolone of alphaxalone and pregnanolone potentiation of [3H]flunitrazepam binding suggests more than one class of binding site for steroids at GABAA receptors. Neuropharmacology. 1993;32:59–63. doi: 10.1016/0028-3908(93)90130-U. PubMed DOI

Sieghart W. Structure, pharmacology, and function of GABAA receptor subtypes. Adv. Pharmacol. 2006;54:231–263. doi: 10.1016/s1054-3589(06)54010-4. PubMed DOI

Chen Z.W., Bracamontes J.R., Budelier M.M., Germann A.L., Shin D.J., Kathiresan K., Qian M.X., Manion B., Cheng W.W.L., Reichert D.E., et al. Multiple functional neurosteroid binding sites on GABAA receptors. PLoS Biol. 2019;17:e3000157. doi: 10.1371/journal.pbio.3000157. PubMed DOI PMC

Shin D.J., Germann A.L., Covey D.F., Steinbach J.H., Akk G. Analysis of GABA A receptor activation by combinations of agonists acting at the same or distinct binding sites. Mol. Pharmacol. 2019;95:70–81. doi: 10.1124/mol.118.113464. PubMed DOI PMC